pancan14h
Research Spotlight
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...
Cure Today9d
Explaining KRAS Mutations For Patients With Colorectal Cancer
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
Scientists identify epigenetic key that 'opens' door to colon cancer
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
southcarolinapublicradio9d
Pancreatic cancer research
Dr. Hawkins: So, there's a lot of new things being developed to try and detect and screen for pancreatic cancer. These are ...
precisionmedicineonline1d
Perthera AI-Driven Predictor Enables Molecularly Guided Therapy for First-Line Pancreatic Cancer Treatment
The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.
Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...